Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.075
▾0.003 (4.17%)
Last trade: 16/04, 8:49AM
Market cap
$15.10m
Market closed
Talk to Bio-Gene Technology Ltd directly.
Sign up to their Investor Hub for direct access to the Bio-Gene Technology Ltd team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Bio-Gene Technology Ltd (BGT) is an Australian public biotechnology company that is developing a patent protected product platform as a new class of insecticides. Bio-Gene owns patents covering the use of these -triketone insecticides for insect control. Bio-Gene's is developing two products targeted at different sectors of the insecticide market. The natural product Qcide - is an oil extracted from the leaves of a rare cultivar of an Australian eucalypt, the Gympie Messmate (Eucalyptus cloeziana). This product is focused on organic insect control. FLAVOCIDE - is a chemically synthesised product developed as a nature identical molecule to molecules also found in Eucalyptus cloeziana extracts.
Address
Level 12/575 Bourke St, Melbourne VIC 3000, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.075
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets